# A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

> **NCT00445172** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 135 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DRUG:** E0302 (mecobalamin)

## Key facts

- **NCT ID:** NCT00445172
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00445172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00445172, "A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00445172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*